Patent · US Active

Otic formulations, methods and devices

US11986483B2 · kind B2 · utility

0Cited by
0References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 8, 2020
Grant dateMay 21, 2024
Priority date
Expiry dateJan 15, 2041

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61M2210/0662
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a formulation and method for treating an ear infection, especially otomycosis and otitis externa, by administering a one-time only treatment comprising an antibiotic, antifungal, and an anti-inflammatory in a thick, otic carrier. In one embodiment, the formulation comprises a therapeutically effective amount of active ingredients including a marbofloxacin, terbinafine and/or clotrimazole and dexamethasone.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.